SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-21-008458
Filing Date
2021-04-30
Accepted
2021-04-30 16:16:44
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A auph-20201231.htm   iXBRL 10-K/A 852663
2 EX-31.2 exhibit312certificationofp.htm EX-31.2 4207
3 EX-31.3 exhibit313certificationofp.htm EX-31.3 4106
  Complete submission text file 0001628280-21-008458.txt   1155327

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20201231.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20201231_cal.xml EX-101.CAL 732
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20201231_def.xml EX-101.DEF 1669
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20201231_lab.xml EX-101.LAB 36135
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20201231_pre.xml EX-101.PRE 19193
9 EXTRACTED XBRL INSTANCE DOCUMENT auph-20201231_htm.xml XML 20275
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36421 | Film No.: 21878236
SIC: 2834 Pharmaceutical Preparations